INGN
Inogen Inc (INGN)
Healthcare • NASDAQ • $6.50+4.00%
- Symbol
- INGN
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical Devices
- Price
- $6.50
- Daily Change
- +4.00%
- Market Cap
- $165.86M
- Trailing P/E
- N/A
- Forward P/E
- -39.06
- 52W High
- $9.13
- 52W Low
- $5.05
- Analyst Target
- $12.00
- Dividend Yield
- 0.00%
- Beta
- 1.50
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Rove 6 concentrator; Inogen Voxi 5, a stationary oxygen concentrator; Aurora for continuous positive airway pressure; CPAP masks; Simeox for airway clearance treatment; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Beverly, Massachusetts.
Company websiteResearch INGN on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.